Literature DB >> 10511523

Influence of host genetics on the severity of coccidioidomycosis.

L Louie1, S Ng, R Hajjeh, R Johnson, D Vugia, S B Werner, R Talbot, W Klitz.   

Abstract

Coccidioidomycosis, a mild flulike illness in approximately 40% of infected persons, progresses to severe pulmonary or disseminated disease in 1% to 10% of symptomatic cases. We examined host genetic influences on disease severity among class II HLA loci and the ABO blood group. Participants included African-American, Caucasian, and Hispanic persons with mild or severe disseminated coccidioidomycosis from Kern County, California. Among Hispanics, predisposition to symptomatic disease and severe disseminated disease is associated with blood types A and B, respectively. The HLA class II DRB1*1301 allele marks a pre-disposition to severe disseminated disease in each of the three groups. Reduced risk for severe disease is associated with DRB1*0301-DQB1*0201 among Caucasians and Hispanics and with DRB1*1501-DQB1*0602 among African-Americans. These data support the hypothesis that host genes, in particular HLA class II and the ABO blood group, influence susceptibility to severe coccidioidomycosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10511523      PMCID: PMC2627717          DOI: 10.3201/eid0505.990508

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  16 in total

1.  Cellular immune response in coccidioidomycosis.

Authors:  A Catanzaro; L E Spitler; K M Moser
Journal:  Cell Immunol       Date:  1975-02       Impact factor: 4.868

Review 2.  Heterogeneity of cytokine secretion patterns and functions of helper T cells.

Authors:  T R Mosmann; R L Coffman
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

3.  Performing the exact test of Hardy-Weinberg proportion for multiple alleles.

Authors:  S W Guo; E A Thompson
Journal:  Biometrics       Date:  1992-06       Impact factor: 2.571

4.  Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice.

Authors:  T N Kirkland; F Finley; K I Orsborn; J N Galgiani
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

5.  An E-M algorithm and testing strategy for multiple-locus haplotypes.

Authors:  J C Long; R C Williams; M Urbanek
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

Review 6.  Class II histocompatibility genes and insulin-dependent diabetes mellitus.

Authors:  S W Serjeantson; S Easteal
Journal:  Mol Biol Med       Date:  1989-06

7.  DNA HLA-DRB1 analysis in children of positive mothers and estimated risk of vertical HIV transmission.

Authors:  N A Greggio; M Cameran; C Giaquinto; F Zacchello; D Koroliuk; V Colizzi
Journal:  Dis Markers       Date:  1993-06       Impact factor: 3.434

8.  Association of ABO blood group and outcome of coccidioidal infection.

Authors:  S C Deresinski; D Pappagianis; D A Stevens
Journal:  Sabouraudia       Date:  1979-09

Review 9.  Epidemiology of coccidioidomycosis.

Authors:  D Pappagianis
Journal:  Curr Top Med Mycol       Date:  1988

10.  HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families.

Authors:  H A Erlich; A Zeidler; J Chang; S Shaw; L J Raffel; W Klitz; Y Beshkov; G Costin; S Pressman; T Bugawan
Journal:  Nat Genet       Date:  1993-04       Impact factor: 38.330

View more
  23 in total

1.  Call for a California coccidioidomycosis consortium to face the top ten challenges posed by a recalcitrant regional disease.

Authors:  George R Thompson; David A Stevens; Karl V Clemons; Josh Fierer; Royce H Johnson; Jane Sykes; George Rutherford; Michael Peterson; John W Taylor; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2014-10-16       Impact factor: 2.574

Review 2.  Coccidioidomycosis in African Americans.

Authors:  Barbara E Ruddy; Anita P Mayer; Marcia G Ko; Helene R Labonte; Jill A Borovansky; Erika S Boroff; Janis E Blair
Journal:  Mayo Clin Proc       Date:  2011-01       Impact factor: 7.616

3.  Association between serum 25-hydroxyvitamin D level and type of coccidioidal infection.

Authors:  George R Thompson; Derek Bays; Sandra L Taylor; Stuart H Cohen; Demosthenes Pappagianis
Journal:  Med Mycol       Date:  2012-06-11       Impact factor: 4.076

4.  In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil.

Authors:  R A Cordeiro; R S N Brilhante; M F G Rocha; M A B Fechine; A K F Costa; Z P Camargo; J J C Sidrim
Journal:  Mycopathologia       Date:  2006-01       Impact factor: 2.574

Review 5.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Pyo-mediastinitis: A complication of pulmonary coccidioidomycosis.

Authors:  Mohamed Y Rady; Arturo Lopez; Bhavesh M Patel; Joel S Larson
Journal:  Can J Infect Dis       Date:  2003-05

7.  Coccidioidomycosis-Associated Deaths in California, 2000-2013.

Authors:  Gail L Sondermeyer; Lauren A Lee; Debra Gilliss; Duc J Vugia
Journal:  Public Health Rep       Date:  2016 Jul-Aug       Impact factor: 2.792

Review 8.  Valley fever: danger lurking in a dust cloud.

Authors:  Larry Johnson; Erin M Gaab; Javier Sanchez; Phuong Q Bui; Clarissa J Nobile; Katrina K Hoyer; Michael W Peterson; David M Ojcius
Journal:  Microbes Infect       Date:  2014-07-16       Impact factor: 2.700

9.  Mycelial forms of Coccidioides spp. in the parasitic phase associated to pulmonary coccidioidomycosis with type 2 diabetes mellitus.

Authors:  B Muñoz-Hernández; M A Martínez-Rivera; G Palma Cortés; A Tapia-Díaz; M E Manjarrez Zavala
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-30       Impact factor: 3.267

10.  Coccidioidomycosis: Epidemiology, Fungal Pathogenesis, and Therapeutic Development.

Authors:  Hazael Hernandez; Victor H Erives; Luis R Martinez
Journal:  Curr Trop Med Rep       Date:  2019-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.